Harringtonine是一种天然的 CephalotaxusCephalotaxus 生物碱,可抑制蛋白质合成蛋白质合成。Harringtonine 具有抗基孔肯雅 (CHIKVCHIKV) 病毒的活性,EC50EC5050 为 0.24 μM。

美国medchemexpress(MCE)浙江省一级代理:杭州昊鑫生物科技股份有限公司美国medchemexpress(MCE)浙江省一级代理:杭州昊鑫生物科技股份有限公司美国medchemexpress(MCE)浙江省一级代理:杭州昊鑫生物科技股份有限公司
MCE中国是全球领先的科研化学品和生物活性化合物供应商,总部位于美国新泽西。我们的产品范围覆盖各种抑制剂、激动剂、API和化合物库。专业、高效的企业灵魂铸造了在行业的卓越地位。热情和充满活力的研发团队拥有着大量的化学和生物科学家。专注于生物活性化合物,拥有着多年的发展历程和丰富的行业经验。从产品的HNMR数据解析到生物活性数据,从客户的询价到产品的售后服务,我们拥有着完善的管理体系,从而保证我们的服务更加高效、准确。努力为中国的医药行业发展注入新的活力,我们将成为您研发工作值得信赖的伙伴。
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
请根据您的
实验动物和给药方式实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照
In VitroIn Vitro 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
——为保证实验结果的可靠性,
澄清的储备液可以根据储存条件,适当保存澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,
建议您现用现配,当天使用建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指
该溶剂在您配制终溶液中的体积占比该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过
加热和/或超声的方式助溶加热和/或超声的方式助溶
- 1.
请依序添加每种溶剂: 10% DMSO 40% PEG300 5% Tween-80 45% saline
Solubility: ≥ 2.5 mg/mL (4.70 mM); Clear solution
- 2.
请依序添加每种溶剂: 10% DMSO 90% (20% SBE-β-CD in saline)
Solubility: ≥ 2.5 mg/mL (4.70 mM); Clear solution
- 3.
请依序添加每种溶剂: 10% DMSO 90% corn oil
Solubility: ≥ 2.5 mg/mL (4.70 mM); Clear solution
1.请依序添加每种溶剂: 10% DMSO 40% PEG300 5% Tween-80 45% saline
Solubility: ≥ 2.5 mg/mL (4.70 mM); Clear solution
1.
请依序添加每种溶剂: 10% DMSO 40% PEG300 5% Tween-80 45% saline
请依序添加每种溶剂: 10% DMSO 40%
PEG300PEG300 5%
Tween-80Tween-80 45% saline
Solubility: ≥ 2.5 mg/mL (4.70 mM); Clear solution
Solubility: ≥ 2.5 mg/mL (4.70 mM); Clear solution
2.请依序添加每种溶剂: 10% DMSO 90% (20% SBE-β-CD in saline)
Solubility: ≥ 2.5 mg/mL (4.70 mM); Clear solution
2.
请依序添加每种溶剂: 10% DMSO 90% (20% SBE-β-CD in saline)
请依序添加每种溶剂: 10% DMSO 90% (20%
SBE-β-CDSBE-β-CD in saline)
Solubility: ≥ 2.5 mg/mL (4.70 mM); Clear solution
Solubility: ≥ 2.5 mg/mL (4.70 mM); Clear solution
3.请依序添加每种溶剂: 10% DMSO 90% corn oil
Solubility: ≥ 2.5 mg/mL (4.70 mM); Clear solution
3.
请依序添加每种溶剂: 10% DMSO 90% corn oil
请依序添加每种溶剂: 10% DMSO 90%
corn oilcorn oil
Solubility: ≥ 2.5 mg/mL (4.70 mM); Clear solution
Solubility: ≥ 2.5 mg/mL (4.70 mM); Clear solution
| 参考文献 | |
|---|
| 参考文献 | |
|---|
参考文献 | 参考文献
| [1]. Fresno M, et al. Inhibition of translation in eukaryotic systems by harringtonine. Eur J Biochem. 1977 Jan;72(2):323-30.
[2]. Kaur P, et al. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression. Antimicrob Agents Chemother. 2013 Jan;57(1):155-67.
[3]. Piao YF, et al. Growth inhibition of human myeloid leukemia cells in vitro by harringtonine. Gan To Kagaku Ryoho. 1990 Feb;17(2):281-5.
[1]. Fresno M, et al. Inhibition of translation in eukaryotic systems by harringtonine. Eur J Biochem. 1977 Jan;72(2):323-30.
[1].
Fresno M, et al. Inhibition of translation in eukaryotic systems by harringtonine. Eur J Biochem. 1977 Jan;72(2):323-30.Fresno M, et al. Inhibition of translation in eukaryotic systems by harringtonine. Eur J Biochem. 1977 Jan;72(2):323-30.
[2]. Kaur P, et al. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression. Antimicrob Agents Chemother. 2013 Jan;57(1):155-67.
[2].
Kaur P, et al. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression. Antimicrob Agents Chemother. 2013 Jan;57(1):155-67.Kaur P, et al. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression. Antimicrob Agents Chemother. 2013 Jan;57(1):155-67.
[3]. Piao YF, et al. Growth inhibition of human myeloid leukemia cells in vitro by harringtonine. Gan To Kagaku Ryoho. 1990 Feb;17(2):281-5.
[3].
Piao YF, et al. Growth inhibition of human myeloid leukemia cells in vitro by harringtonine. Gan To Kagaku Ryoho. 1990 Feb;17(2):281-5.Piao YF, et al. Growth inhibition of human myeloid leukemia cells in vitro by harringtonine. Gan To Kagaku Ryoho. 1990 Feb;17(2):281-5.